These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1780700)

  • 1. Intravesical BCG therapy in bladder carcinoma. Effect on cytotoxicity, IL-2 production and phenotype of peripheral blood mononuclear cells.
    Hermann GG; Petersen KR; Zeuthen J; Steven K
    Scand J Urol Nephrol; 1991; 25(4):269-73. PubMed ID: 1780700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukocytes in the urine after intravesical BCG treatment for superficial bladder cancer. A flow cytofluorometric analysis.
    de Boer EC; de Jong WH; van der Meijden AP; Steerenberg PA; Witjes F; Vegt PD; Debruyne FM; Ruitenberg EJ
    Urol Res; 1991; 19(1):45-50. PubMed ID: 2028562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic immune response after intravesical instillation of bacille Calmette-Guérin (BCG) for superficial bladder cancer.
    Taniguchi K; Koga S; Nishikido M; Yamashita S; Sakuragi T; Kanetake H; Saito Y
    Clin Exp Immunol; 1999 Jan; 115(1):131-5. PubMed ID: 9933432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local immune responses after intravesical BCG treatment for carcinoma in situ.
    el-Demiry MI; Smith G; Ritchie AW; James K; Cumming JA; Hargreave TB; Chisholm GD
    Br J Urol; 1987 Dec; 60(6):543-8. PubMed ID: 3501324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravesical Evans strain BCG therapy: quantitative immunohistochemical analysis of the immune response within the bladder wall.
    Prescott S; James K; Hargreave TB; Chisholm GD; Smyth JF
    J Urol; 1992 Jun; 147(6):1636-42. PubMed ID: 1593713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-DR expression by high grade superficial bladder cancer treated with BCG.
    Prescott S; James K; Busuttil A; Hargreave TB; Chisholm GD; Smyth JF
    Br J Urol; 1989 Mar; 63(3):264-9. PubMed ID: 2522806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution and clinical significance of the T cell proliferative and cytokine response directed against the fibronectin binding antigen 85 complex of bacillus Calmette-Guerin during intravesical treatment of superficial bladder cancer.
    Zlotta AR; Drowart A; Van Vooren JP; de Cock M; Pirson M; Palfliet K; Jurion F; Vanonckelen A; Simon J; Schulman CC; Huygen K
    J Urol; 1997 Feb; 157(2):492-8. PubMed ID: 8996341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative stress of red blood cells during Bacillus Calmette-Guerin intravesical instillations.
    Mitropoulos D; Deliconstantinos G; Zervas A; Giannopoulos A; Kyriakou G; Dimopoulos C
    In Vivo; 2000; 14(6):721-4. PubMed ID: 11204488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of action of intravesical bacille Calmette-Guérin: local immune mechanisms.
    Prescott S; Jackson AM; Hawkyard SJ; Alexandroff AB; James K
    Clin Infect Dis; 2000 Sep; 31 Suppl 3():S91-3. PubMed ID: 11010831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bacillus Calmette-Guerin intravesical instillation treatment for carcinoma in situ of the bladder. Gifu BCG Instillation Therapy Research Group].
    Nishino Y; Yasuda M; Yokoi S; Ehara H; Yamamoto N; Takahashi Y; Ishihara S; Deguchi T; Kawada Y; Takeda A; Sakai S; Takeuchi T; Taniguchi M; Minoshima K; Hamamoto Y; Kanimoto Y; Nakano M; Fujihiro S; Nezasa S; Matsuda T; Nagatani Y; Maeda S; Tamaki M; Saito A; Komeda H
    Gan To Kagaku Ryoho; 1999 Oct; 26(12):1869-73. PubMed ID: 10560414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-2 production during intravesical bacille Calmette-Guerin therapy for bladder cancer.
    Ratliff TL; Haaff EO; Catalona WJ
    Clin Immunol Immunopathol; 1986 Aug; 40(2):375-9. PubMed ID: 3487405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of interleukin 2 in the urine of patients with superficial bladder tumors after treatment with intravesical BCG.
    Haaff EO; Catalona WJ; Ratliff TL
    J Urol; 1986 Oct; 136(4):970-4. PubMed ID: 3489840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Invasive bladder cancer with concomitant carcinoma in situ treated with chemoradiotherapy followed by BCG intravesical infusion therapy to preserve the bladder : report of three cases].
    Ohzeki T; Hashimoto K; Katoh Y; Iguchi M
    Hinyokika Kiyo; 2011 Oct; 57(10):581-4. PubMed ID: 22089159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of side effects of intravesical therapy with bacille Calmette-Guérin by pentoxifylline?--an in vitro approach.
    Böhle A; Thanhäuser A; Ernst M; Flad HD; Rüsch-Gerdes S; Jocham D; Ulmer AJ
    Clin Infect Dis; 2000 Sep; 31 Suppl 3():S101-5. PubMed ID: 11010833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of tumor-associated macrophages count in human non-muscle-invasive bladder cancer treated by BCG immunotherapy.
    Ajili F; Kourda N; Darouiche A; Chebil M; Boubaker S
    Ultrastruct Pathol; 2013 Feb; 37(1):56-61. PubMed ID: 23383616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of early failures after intravesical instillation therapy with bacille Calmette-Guérin for carcinoma in situ of the bladder.
    Merz VW; Marth D; Kraft R; Ackermann DK; Zingg EJ; Studer UE
    Br J Urol; 1995 Feb; 75(2):180-4. PubMed ID: 7850322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravesical Bacillus Calmette Guerin Combined with a Cancer Vaccine Increases Local T-Cell Responses in Non-muscle-Invasive Bladder Cancer Patients.
    Derré L; Cesson V; Lucca I; Cerantola Y; Valerio M; Fritschi U; Vlamopoulos Y; Burruni R; Legris AS; Dartiguenave F; Gharbi D; Martin V; Vaucher L; Speiser DE; Romero P; Jichlinski P; Nardelli-Haefliger D
    Clin Cancer Res; 2017 Feb; 23(3):717-725. PubMed ID: 27521445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of carcinoma in situ of the urinary bladder with BCG].
    Schnyder von Wartensee M; Ackermann D; Studer UE; Zingg EJ
    Helv Chir Acta; 1989 Aug; 56(3):351-4. PubMed ID: 2807965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble urinary CD14 after intravesical bacille Calmette-Guérin immunotherapy for carcinoma in situ.
    Jackson AM; Lien E; Alexandroff AB; Prescott S; Espevik T; James K; Selby PJ; Sundan A
    Br J Urol; 1997 Nov; 80(5):766-71. PubMed ID: 9393300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intravesical BCG vaccine in bladder cancer].
    Beisland HO; Sander S
    Tidsskr Nor Laegeforen; 1989 Jun; 109(17-18):1891-2. PubMed ID: 2749672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.